Guidelines for pregnant women with suspected SARS-CoV-2 infection
Identifieur interne : 000B13 ( Pmc/Corpus ); précédent : 000B12; suivant : 000B14Guidelines for pregnant women with suspected SARS-CoV-2 infection
Auteurs : Guillaume Favre ; Léo Pomar ; Xiaolong Qi ; Karin Nielsen-Saines ; Didier Musso ; David BaudSource :
- The Lancet. Infectious Diseases [ 1473-3099 ] ; 2020.
Url:
DOI: 10.1016/S1473-3099(20)30157-2
PubMed: 32142639
PubMed Central: 7134390
Links to Exploration step
PMC:7134390Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Guidelines for pregnant women with suspected SARS-CoV-2 infection</title><author><name sortKey="Favre, Guillaume" sort="Favre, Guillaume" uniqKey="Favre G" first="Guillaume" last="Favre">Guillaume Favre</name><affiliation><nlm:aff id="aff1">Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, 1011 Lausanne, Switzerland</nlm:aff></affiliation></author><author><name sortKey="Pomar, Leo" sort="Pomar, Leo" uniqKey="Pomar L" first="Léo" last="Pomar">Léo Pomar</name><affiliation><nlm:aff id="aff1">Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, 1011 Lausanne, Switzerland</nlm:aff></affiliation></author><author><name sortKey="Qi, Xiaolong" sort="Qi, Xiaolong" uniqKey="Qi X" first="Xiaolong" last="Qi">Xiaolong Qi</name><affiliation><nlm:aff id="aff2">CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China</nlm:aff></affiliation></author><author><name sortKey="Nielsen Saines, Karin" sort="Nielsen Saines, Karin" uniqKey="Nielsen Saines K" first="Karin" last="Nielsen-Saines">Karin Nielsen-Saines</name><affiliation><nlm:aff id="aff3">Division of Pediatric Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA</nlm:aff></affiliation></author><author><name sortKey="Musso, Didier" sort="Musso, Didier" uniqKey="Musso D" first="Didier" last="Musso">Didier Musso</name><affiliation><nlm:aff id="aff4">Aix Marseille Université, IRD, AP-HM, SSA, VITROME, IHU—Méditerranée infection, Marseille, France</nlm:aff></affiliation><affiliation><nlm:aff id="aff5">Laboratoire Eurofins Labazur Guyane, French Guiana, France</nlm:aff></affiliation></author><author><name sortKey="Baud, David" sort="Baud, David" uniqKey="Baud D" first="David" last="Baud">David Baud</name><affiliation><nlm:aff id="aff1">Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, 1011 Lausanne, Switzerland</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">32142639</idno><idno type="pmc">7134390</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134390</idno><idno type="RBID">PMC:7134390</idno><idno type="doi">10.1016/S1473-3099(20)30157-2</idno><date when="2020">2020</date><idno type="wicri:Area/Pmc/Corpus">000B13</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B13</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Guidelines for pregnant women with suspected SARS-CoV-2 infection</title><author><name sortKey="Favre, Guillaume" sort="Favre, Guillaume" uniqKey="Favre G" first="Guillaume" last="Favre">Guillaume Favre</name><affiliation><nlm:aff id="aff1">Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, 1011 Lausanne, Switzerland</nlm:aff></affiliation></author><author><name sortKey="Pomar, Leo" sort="Pomar, Leo" uniqKey="Pomar L" first="Léo" last="Pomar">Léo Pomar</name><affiliation><nlm:aff id="aff1">Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, 1011 Lausanne, Switzerland</nlm:aff></affiliation></author><author><name sortKey="Qi, Xiaolong" sort="Qi, Xiaolong" uniqKey="Qi X" first="Xiaolong" last="Qi">Xiaolong Qi</name><affiliation><nlm:aff id="aff2">CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China</nlm:aff></affiliation></author><author><name sortKey="Nielsen Saines, Karin" sort="Nielsen Saines, Karin" uniqKey="Nielsen Saines K" first="Karin" last="Nielsen-Saines">Karin Nielsen-Saines</name><affiliation><nlm:aff id="aff3">Division of Pediatric Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA</nlm:aff></affiliation></author><author><name sortKey="Musso, Didier" sort="Musso, Didier" uniqKey="Musso D" first="Didier" last="Musso">Didier Musso</name><affiliation><nlm:aff id="aff4">Aix Marseille Université, IRD, AP-HM, SSA, VITROME, IHU—Méditerranée infection, Marseille, France</nlm:aff></affiliation><affiliation><nlm:aff id="aff5">Laboratoire Eurofins Labazur Guyane, French Guiana, France</nlm:aff></affiliation></author><author><name sortKey="Baud, David" sort="Baud, David" uniqKey="Baud D" first="David" last="Baud">David Baud</name><affiliation><nlm:aff id="aff1">Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, 1011 Lausanne, Switzerland</nlm:aff></affiliation></author></analytic><series><title level="j">The Lancet. Infectious Diseases</title><idno type="ISSN">1473-3099</idno><idno type="eISSN">1474-4457</idno><imprint><date when="2020">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Alfaraj, Sh" uniqKey="Alfaraj S">SH Alfaraj</name></author><author><name sortKey="Al Tawfiq, Ja" uniqKey="Al Tawfiq J">JA Al-Tawfiq</name></author><author><name sortKey="Memish, Za" uniqKey="Memish Z">ZA Memish</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wong, Sf" uniqKey="Wong S">SF Wong</name></author><author><name sortKey="Chow, Km" uniqKey="Chow K">KM Chow</name></author><author><name sortKey="Leung, Tn" uniqKey="Leung T">TN Leung</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, H" uniqKey="Chen H">H Chen</name></author><author><name sortKey="Guo, Juanjuan" uniqKey="Guo J">Juanjuan Guo</name></author><author><name sortKey="Wang, C" uniqKey="Wang C">C Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Favre, G" uniqKey="Favre G">G Favre</name></author><author><name sortKey="Pomar, L" uniqKey="Pomar L">L Pomar</name></author><author><name sortKey="Musso, D" uniqKey="Musso D">D Musso</name></author><author><name sortKey="Baud, D" uniqKey="Baud D">D Baud</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Musso, D" uniqKey="Musso D">D Musso</name></author><author><name sortKey="Ko, Ai" uniqKey="Ko A">AI Ko</name></author><author><name sortKey="Baud, D" uniqKey="Baud D">D Baud</name></author></analytic></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="letter"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Lancet Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Lancet Infect Dis</journal-id><journal-title-group><journal-title>The Lancet. Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1473-3099</issn><issn pub-type="epub">1474-4457</issn><publisher><publisher-name>Elsevier Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32142639</article-id><article-id pub-id-type="pmc">7134390</article-id><article-id pub-id-type="publisher-id">S1473-3099(20)30157-2</article-id><article-id pub-id-type="doi">10.1016/S1473-3099(20)30157-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Guidelines for pregnant women with suspected SARS-CoV-2 infection</article-title></title-group><contrib-group><contrib contrib-type="author" id="au10"><name><surname>Favre</surname><given-names>Guillaume</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au20"><name><surname>Pomar</surname><given-names>Léo</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au30"><name><surname>Qi</surname><given-names>Xiaolong</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au40"><name><surname>Nielsen-Saines</surname><given-names>Karin</given-names></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au50"><name><surname>Musso</surname><given-names>Didier</given-names></name><xref rid="aff4" ref-type="aff">d</xref><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="au60"><name><surname>Baud</surname><given-names>David</given-names></name><email>david.baud@chuv.ch</email><xref rid="aff1" ref-type="aff">a</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Materno-fetal and Obstetrics Research Unit, Department Woman-Mother-Child, Lausanne University Hospital, 1011 Lausanne, Switzerland</aff><aff id="aff2"><label>b</label>CHESS Center, The First Hospital of Lanzhou University, Lanzhou, China</aff><aff id="aff3"><label>c</label>Division of Pediatric Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA</aff><aff id="aff4"><label>d</label>Aix Marseille Université, IRD, AP-HM, SSA, VITROME, IHU—Méditerranée infection, Marseille, France</aff><aff id="aff5"><label>e</label>Laboratoire Eurofins Labazur Guyane, French Guiana, France</aff><pub-date pub-type="pmc-release"><day>3</day><month>3</month><year>2020</year></pub-date><pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="epub"><day>3</day><month>3</month><year>2020</year></pub-date><elocation-id></elocation-id><permissions><copyright-statement>© 2020 Elsevier Ltd. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Elsevier Ltd</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></article-meta></front><body><p id="para10">Coronaviruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) can cause severe adverse pregnancy outcomes, such as miscarriage, premature delivery, intrauterine growth restriction, and maternal death.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref> Vertical transmission of the virus responsible for 2019 novel coronavirus disease (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has not yet been detected, whereas perinatal transmission has been suspected in one case.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref></p><p id="para20">Consequences of infection with SARS-CoV-2 for pregnancies are uncertain, with no evidence so far of severe outcomes for mothers and infants; however, the possibility should be considered.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> The recent experience with Zika virus suggests that when a new pathogen emerges, the health-care community should be prepared for the worst-case scenario.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Therefore, recommendations for management of pregnant women at risk of SARS-CoV-2 infection are urgently needed. To this end, we propose a detailed management algorithm for health-care providers (<xref rid="sec1" ref-type="sec">appendix</xref>).</p><p id="para30">In the algorithm, we suggest that any pregnant woman who has travelled in a country affected by SARS-CoV-2 within the previous 14 days or who has had close contact with a patient with confirmed SARS-CoV-2 infection should be tested with a SARS-CoV-2 nucleic acid amplification test,<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> even if asymptomatic. Pregnant women with laboratory-confirmed SARS-CoV-2 infection who are asymptomatic should be self-monitored at home for clinical features of COVID-19 for at least 14 days. These patients and those recovering from mild illness should be monitored with bimonthly fetal growth ultrasounds and Doppler assessments because of the potential risk for intrauterine growth restriction. Pregnant women with COVID-19 pneumonia should be managed by a multidisciplinary team at a tertiary care centre. When quick Sepsis-related Organ Failure Assessment criteria are met, the patient should be transferred to an intensive care unit.</p><p id="para40">For pregnant women with confirmed infection, the choice of delivery timing should be individualised depending on the week of gestation and maternal, fetal, and delivery conditions. Whenever possible, vaginal delivery via induction of labour, with eventual instrumental delivery to avoid maternal exhaustion, should be favoured to avoid unnecessary surgical complications in an already sick patient. Septic shock, acute organ failure, or fetal distress should prompt emergency cesarean delivery (or termination if legal before fetal viability).</p><p id="para50">Newborns of mothers positive for SARS-CoV-2 should be isolated for at least 14 days or until viral shedding clears, during which time direct breastfeeding is not recommended.</p><p id="para60">These recommendations should be adapted to local health-care facilities, as well as in response to any further updates on SARS-CoV-2 and COVID-19.</p></body><back><ref-list id="bibl10"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sbref10"><person-group person-group-type="author"><name><surname>Alfaraj</surname><given-names>SH</given-names></name><name><surname>Al-Tawfiq</surname><given-names>JA</given-names></name><name><surname>Memish</surname><given-names>ZA</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases & review of the literature</article-title><source>J Microbiol Immunol Infect</source><volume>52</volume><year>2019</year><fpage>501</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">29907538</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sbref20"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>SF</given-names></name><name><surname>Chow</surname><given-names>KM</given-names></name><name><surname>Leung</surname><given-names>TN</given-names></name></person-group><article-title>Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome</article-title><source>Am J Obstet Gynecol</source><volume>191</volume><year>2004</year><fpage>292</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">15295381</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sbref30"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>Juanjuan</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name></person-group><article-title>Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records</article-title><source>Lancet</source><year>2020</year><comment>published online Feb 12.</comment><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30360-3</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sbref40"><person-group person-group-type="author"><name><surname>Favre</surname><given-names>G</given-names></name><name><surname>Pomar</surname><given-names>L</given-names></name><name><surname>Musso</surname><given-names>D</given-names></name><name><surname>Baud</surname><given-names>D</given-names></name></person-group><article-title>2019-nCoV epidemic: what about pregnancies?</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>e40</fpage><pub-id pub-id-type="pmid">32035511</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sbref50"><person-group person-group-type="author"><name><surname>Musso</surname><given-names>D</given-names></name><name><surname>Ko</surname><given-names>AI</given-names></name><name><surname>Baud</surname><given-names>D</given-names></name></person-group><article-title>Zika virus infection—after the pandemic</article-title><source>N Engl J Med</source><volume>381</volume><year>2019</year><fpage>1444</fpage><lpage>1457</lpage><pub-id pub-id-type="pmid">31597021</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="book" id="sbref60"><person-group person-group-type="author"><collab>WHO</collab></person-group><chapter-title>Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance</chapter-title><year>2020</year><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva</publisher-loc></element-citation></ref></ref-list><sec id="sec1" sec-type="supplementary-material"><title>Supplementary Material</title><p id="para80"><supplementary-material content-type="local-data" id="ecomp10"><caption><title>Supplementary appendix</title></caption><media xlink:href="mmc1.pdf"></media></supplementary-material></p></sec><ack><p>We declare no competing interests.</p></ack></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B13 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000B13 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:7134390
|texte= Guidelines for pregnant women with suspected SARS-CoV-2 infection
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:32142639" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |